Get started
Author

Brian J. Grindel

Observed names: B Grindel, B.J. Grindel, Brian Grindel, Brian J Grindel, Grindel, Brian
OpenAlex ID: A5081753385
Perlecan/ Hspg2 deficiency alters the pericellular space of the lacunocanalicular system surrounding osteocytic processes in cortical bone
2010 · William R Thompson, Shannon Modla, et al. · Journal of Bone and Mineral Research · 120
PDF
Directing evolution of novel ligands by mRNA display
2021 · Golnaz Kamalinia, Brian J. Grindel, et al. · Chemical Society Reviews · 98
Matrilysin/matrix metalloproteinase-7(MMP7) cleavage of perlecan/HSPG2 creates a molecular switch to alter prostate cancer cell behavior
2014 · B.J. Grindel, J.R. Martinez, et al. · Matrix Biology · 79
PDF
Single molecule force measurements of perlecan/HSPG2: A key component of the osteocyte pericellular matrix
2015 · Sithara S. Wijeratne, Jerahme R. Martinez, et al. · Matrix Biology · 46
PDF
Transcriptional Activation by NFκB Increases Perlecan/HSPG2 Expression in the Desmoplastic Prostate Tumor Microenvironment
2014 · Curtis R. Warren, Brian J. Grindel, et al. · Journal of Cellular Biochemistry · 43
Matrilysin/MMP-7 Cleavage of Perlecan/HSPG2 Complexed with Semaphorin 3A Supports FAK-Mediated Stromal Invasion by Prostate Cancer Cells
2018 · Brian J. Grindel, Jerahme R. Martinez, et al. · Scientific Reports · 41
PDF
Directed evolution of cyclic peptides for inhibition of autophagy
2021 · Joshua P. Gray, Md. Nasir Uddin, et al. · Chemical Science · 38
PDF
Perlecan/HSPG2 and matrilysin/MMP-7 as indices of tissue invasion: tissue localization and circulating perlecan fragments in a cohort of 288 radical prostatectomy patients
2016 · Brian Grindel, Quanlin Li, et al. · Oncotarget · 34
Tumor necrosis factor‐α treatment of HepG2 cells mobilizes a cytoplasmic pool of ERp57/1,25D 3 ‐MARRS to the nucleus
2011 · Brian J. Grindel, Benjamin Rohe, et al. · Journal of Cellular Biochemistry · 26
Chaperone Properties of Pdia3 Participate in Rapid Membrane Actions of 1α,25-Dihydroxyvitamin D3
2013 · Jiaxuan Chen, Kirill S. Lobachev, et al. · Molecular Endocrinology · 25
Sustained delivery of recombinant human bone morphogenetic protein‐2 from perlecan domain I ‐ functionalized electrospun poly (ε‐caprolactone) scaffolds for bone regeneration
2016 · Yu‐Chieh Chiu, Eliza L. Fong, et al. · Journal of Experimental Orthopaedics · 22
PDF
Cleavage of the Perlecan-Semaphorin 3A-Plexin A1-Neuropilin-1 (PSPN) Complex by Matrix Metalloproteinase 7/Matrilysin Triggers Prostate Cancer Cell Dyscohesion and Migration
2021 · Tristen V. Tellman, Lissette A. Cruz, et al. · International Journal of Molecular Sciences · 20
PDF
Perlecan/HSPG2: Signaling role of domain IV in chondrocyte clustering with implications for Schwartz‐Jampel Syndrome
2018 · Jerahme R. Martinez, Brian J. Grindel, et al. · Journal of Cellular Biochemistry · 18
Directed Evolution of PD-L1-Targeted Affibodies by mRNA Display
2022 · Brian J. Grindel, Brian J. Engel, et al. · ACS Chemical Biology · 17
PDF
mRNA Display Discovery of a Novel Programmed Death Ligand 1 (PD-L1) Binding Peptide (a Peptide Ligand for PD-L1)
2020 · Golnaz Kamalinia, Brian J. Engel, et al. · ACS Chemical Biology · 15
Purification of poly-dA oligonucleotides and mRNA-protein fusions with dT25-OAS resin
2019 · Brian J. Engel, Brian J. Grindel, et al. · Bioorganic & Medicinal Chemistry Letters · 15
Directional conjugation of monoclonal antibodies to nanoparticles using metal-free click chemistry
2025 · Ananthakrishnan S. Jeevarathinam, Mohammed R. Kawelah, et al. · Nature Protocols · 6
PDF
Gender Differences in a Mouse Model of Hepatocellular Carcinoma Revealed Using Multi-Modal Imaging
2023 · Brian J. Engel, Vincenzo Paolillo, et al. · Cancers · 4
PDF
Mammalian Expression and In Situ Biotinylation of Extracellular Protein Targets for Directed Evolution
2020 · Brian J. Grindel, Brian J. Engel, et al. · ACS Omega · 4
Correction: Perlecan/HSPG2 and matrilysin/MMP-7 as indices of tissue invasion: tissue localization and circulating perlecan fragments in a cohort of 288 radical prostatectomy patients
2016 · Brian Grindel, Quanlin Li, et al. · Oncotarget · 4
PDF
Using extension‐based mRNA display to design antibody‐like proteinogenic peptides for human PD ‐ L1
2025 · Justin N. Ong, Brian J. Grindel, et al. · Protein Science · 3
PDF
Abstract 66: MMP-7 cleavage of the Perlecan-Sema3A-Plexin(A1)-Neuropilin-1 complex promotes the progression of metastatic prostate cancer
2019 · Tristen V. Tellman, Lissette A. Cruz, et al. · Cancer Research · 2
Abstract 67: MMP-7 decreases E-cadherin localization at cell-cell contacts resulting in F-actin cytoskeletal remodeling in prostate cancer micro-tumors formed by perlecan/HSPG2
2019 · Lissette A. Cruz, Tristen V. Tellman, et al. · Cancer Research · 1
Abstract 2650: Perlecan-Semaphorin 3A-Plexin A1-Neuropilin-1 complex: Flipping the switch controlling metastatic behavior of prostate cancer cells
2020 · Tristen V. Tellman, Lissette A. Cruz, et al. · Cancer Research
Abstract 2608: MMP-7 increases migration by decreasing intercellular E-cadherin and F-actin localization in prostate cancer micro-tumors formed by perlecan/HSPG2
2020 · Lissette A. Cruz, Tristen V. Tellman, et al. · Cancer Research
Works count: 37
Citation count: 681
H-index: 15
I10-index: 16
Year
Topic
Type